Metabolic and biosynthetic alterations in cultured astrocytes exposed to hypoxia/reoxygenation.
To investigate the astrocyte response to hypoxia/reoxygenation, as a model relevant to the pathogenesis of ischemic injury, cultured rat astrocytes were exposed to hypoxia. On restoration of astrocytes to normoxia, there was a dramatic increase in protein synthesis within 3 h, and sodium dodecyl sulfate-polyacrylamide gel electrophoresis of metabolically labeled astrocyte lysates showed multiple induced bands on fluorograms. Levels of cellular ATP declined during the first 3 h of reoxygenation and the concentration of AMP increased to approximately 3.6 nmol/mg of protein within 1 h of reoxygenation. Reoxygenated astrocytes generated oxygen free radicals early after replacement into ambient air, and addition of diphenyliodonium, an NADPH oxidase inhibitor, diminished the generation of free radicals as well as the induction of several bands on fluorogram. Although addition of cycloheximide on reoxygenation resulted in inhibition of both astrocyte protein synthesis and accumulation of cellular AMP, it caused cell death within 6 h, suggesting the importance of protein synthesis in adaptation of hypoxic astrocytes to reoxygenation. Potential physiologic significance of biosynthetic products of astrocytes in hypoxia/reoxygenation was suggested by the recovery of glutamate uptake. These results indicate that the astrocyte response to hypoxia/reoxygenation includes generation of oxygen free radicals and de novo synthesis of products that influence cell viability and function in ischemia.
Hori
O
O
First Department of Medicine, Osaka University Medical School Hospital, Japan.
Matsumoto
M
M
Maeda
Y
Y
Ueda
H
H
Ohtsuki
T
T
Stern
D M
DM
Kinoshita
T
T
Ogawa
S
S
Kamada
T
T
D000249:Adenosine Monophosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism*; D001713:Biphenyl Compounds / Q000494:pharmacology; D001921:Brain / Q000166:cytology; D002470:Cell Survival; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D004734:Energy Metabolism; D005609:Free Radicals; D005971:Glutamates / Q000378:metabolism; D018698:Glutamic Acid; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D009861:Onium Compounds / Q000494:pharmacology; D010100:Oxygen / Q000008:administration & dosage* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
D001713:Biphenyl Compounds; D005609:Free Radicals; D005971:Glutamates; D009419:Nerve Tissue Proteins; D009861:Onium Compounds; C031291:diphenyliodonium; D018698:Glutamic Acid; D000249:Adenosine Monophosphate; D000255:Adenosine Triphosphate; D003513:Cycloheximide; D010100:Oxygen